Triflubazam
Systematic (IUPAC) name | |
---|---|
1-methyl- 5-phenyl- 7-(trifluoromethyl)- 1H-1,5-benzodiazepine- 2,4(3H,5H)-dione | |
Clinical data | |
Identifiers | |
22365-40-8 | |
None | |
PubChem | CID 31157 |
ChemSpider | 28907 |
UNII | 80D8H0388T |
Chemical data | |
Formula | C17H13F3N2O2 |
334.29 | |
SMILES
| |
| |
(what is this?) (verify) |
Triflubazam[1] is a drug which is a 1,5-benzodiazepine derivative, related to clobazam.[2] It has sedative and anxiolytic effects, with a long half-life and duration of action.[3][4][5]
See also
References
- ↑ US Patent 3660381 -5-ARYL-1H-1 5-BENZODIAZEPINE-2 4-DIONES
- ↑ Lundbeck Institute (2003). "triflubazam". psychotropics.dk. Retrieved 17 November 2010.
- ↑ Itil TM, Akpinar S, Fink M: Controlled clinical and quantitative EEG studies of triflubazam (ORF 8063) in patients with anxiety syndrome. Current Therapeutic Research 1976; 19: 307-315
- ↑ Csanalosi I, Pereira-Oran J, Case G, et al.: Triflubazam (ORF 8063), a new benzodiazepine in anxiety neurosis. Current Therapeutic Research 1977; 22: 166-171
- ↑ Nicholson AN, Stone BM, Clarke CH. Effect of the 1,5-benzodiazepines, clobazam and triflubazam, on sleep in man. British Journal of Clinical Pharmacology. 1977 Oct;4(5):567-72.
|